NCT06061445 2024-04-12
Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital
Phase NA Unknown
Clinical Trials
202 trialsNCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
NCT06335147 2024-03-28
PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer
Henan Cancer Hospital
Phase NA Unknown
NCT06250166 2024-02-28
Feasibility, Acceptability, and Effectiveness of an Individualized Plant-based (iPLANT) Diet Plan in Colorectal Cancer: Mixed Method Embedded Design
National Cancer Institute, Malaysia
Phase NA Unknown
NCT06277908 2024-02-26
GASTROSTAT
P. Herzen Moscow Oncology Research Institute
Unknown
NCT06260150 2024-02-15
Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.
Shandong Provincial Hospital
Phase NA Unknown
NCT06227325 2024-01-26
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Phase 2 Unknown
NCT06197438 2024-01-09
Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT05088889 2023-11-28
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
Phase 1 Unknown
NCT05147168 2023-11-14
Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan
Taipei Veterans General Hospital, Taiwan
Unknown
NCT05394246 2023-08-30
Fluorescent-labeled IgG for Liver Tumor Detection
Chinese Academy of Sciences
Phase NA Unknown
NCT05688020 2023-08-09
Tranexamic Acid During Upper GI Endoscopic Resection Procedures
Assaf-Harofeh Medical Center
Phase 4 Unknown
NCT05319054 2023-07-20
POLARiS
Cardiff and Vale University Health Board
Phase NA Unknown
NCT05927844 2023-07-03
XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma
Fujian Cancer Hospital
Phase 1 Unknown
NCT05785975 2023-06-26
ColonCancer
The New Model of Care, Hail Health Cluster
Phase NA Unknown
NCT05751265 2023-06-22
Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT05913570 2023-06-22
MSI-H/dMMR
Henan Cancer Hospital
Phase 2 Unknown
NCT05914597 2023-06-22
5GSUCCEEDS
National Health Service, United Kingdom
Phase NA Unknown
NCT05099237 2023-05-03
EMBRaCE-GM
Manchester University NHS Foundation Trust
Phase NA Unknown
NCT05799443 2023-04-05
Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT03173001 2023-03-03
Possible Association of Intestinal Helminths and Protozoa With Colorectal Cancer Pathogenesis
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Unknown
NCT05750290 2023-03-01
CKD-702 Plus Irinotecan in Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT05690490 2023-01-19
C-EMR
State Scientific Centre of Coloproctology, Russian Federation
Phase NA Unknown
NCT04077255 2022-11-30
EGFR-targeted Therapy for Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT04893252 2022-11-30
Vactosertib and Durvalumab in Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT05608785 2022-11-08
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
Henan Cancer Hospital
Phase 1/2 Unknown
NCT05592925 2022-10-25
MA
Shandong Provincial Hospital
Unknown
NCT02773485 2022-10-21
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
Tata Memorial Hospital
Phase 3 Unknown
NCT05545124 2022-09-19
Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence
Henan Cancer Hospital
Phase 2 Unknown
NCT05493956 2022-09-09
RACE-GB
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Phase NA Unknown
NCT04801355 2022-08-25
FlexLaC
State Scientific Centre of Coloproctology, Russian Federation
Phase NA Unknown
NCT05314101 2022-08-23
TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT04598984 2022-08-08
The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer
Istanbul Training and Research Hospital
Unknown
NCT04857203 2022-08-08
The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer
Istanbul Training and Research Hospital
Unknown
NCT05442138 2022-07-29
A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients
Henan Cancer Hospital
Unknown
NCT02959541 2022-06-13
PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer
Vastra Gotaland Region
Phase NA Unknown
NCT05391867 2022-05-26
Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma
Sir Salimullah Medical College Mitford Hospital
Phase NA Unknown
NCT05331040 2022-04-29
Radiomics in Rectal Cancer
NHS Grampian
Unknown
NCT02794337 2022-04-27
TACE-SBRT
Tata Memorial Hospital
Phase 2/3 Unknown
NCT05335460 2022-04-19
To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT04675866 2022-04-15
Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer
Henan Cancer Hospital
Phase NA Unknown
NCT05319392 2022-04-15
GAC
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Unknown
NCT05322486 2022-04-11
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
State Scientific Centre of Coloproctology, Russian Federation
Unknown
NCT03957733 2022-04-06
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
King Abdullah Medical City
Phase 2/3 Unknown
NCT05313906 2022-04-06
RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT05024539 2022-04-05
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma
Henan Cancer Hospital
Unknown
NCT05023720 2022-04-01
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer
Henan Cancer Hospital
Unknown
NCT05266820 2022-03-18
Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT05270564 2022-03-08
Drain 1
Linkoeping University
Phase NA Unknown
NCT05162898 2022-01-27
Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.
Henan Cancer Hospital
Phase NA Unknown